Navigation Links
The potential of psilocybin to alleviate psychological distress in cancer patients is revealed
Date:1/31/2013

Improvements in the diagnosis and treatment of cancers in recent years have led to a marked increase in patients' physical survival rates. While doctors can treat the physical disease, what is not well understood is how best to address the psychological needs of patients with cancer.

In addition to the physical pain associated with cancer, many patients also experience psychologically harmful symptoms of anxiety, depression, anger, and denial. Social isolation, in addition to hopelessness, helplessness and loss of independence, has also been associated with significant psychological suffering in patients coping with advanced-stage cancer.

A recently published book chapter "Use of the Classic Hallucinogen Psilocybin for Treatment of Existential Distress Associated with Cancer," reviews the potential of a novel psychoactive drug, psilocybin, in alleviating the psychological and spiritual distress that often accompanies a life-threatening cancer diagnosis.

The chapter, published in Psychological Aspects of Cancer: A Guide to Emotional and Psychological Consequences of Cancer, Their Causes, and Their Management, was co-written by Anthony P. Bossis, PhD, Clinical Assistant Professor of Psychiatry and Oral and Maxillofacial Pathology, Radiology, and Medicine at the New York University College of Dentistry (NYUCD) and Langone Medical Center.

The hallucinogen treatment model with psilocybin has been shown to induce a mystical or spiritual experience and is a unique therapeutic approach to reduce the anxiety of terminal cancer patients.

"Mystical or peak consciousness states in cancer patients have been associated with a number of benefits including improved psychological, spiritual, and existential well-being," said Dr. Bossis.

Psilocybin (a serotonergic psychoactive agent) is a naturally occurring active component of many species of mushrooms, and is rapidly metabolized to psilocin, a highly potent acti
'/>"/>

Contact: Christopher James
christopher.james@nyu.edu
212-998-6876
New York University
Source:Eurekalert

Page: 1 2

Related biology news :

1. BUSM study shows potential of differentiated iPS cells in cell therapy without immune rejection
2. Underwater CO2 shows potential as barrier to Asian carp
3. Circadian rhythms can be modified for potential treatment of disorders
4. Potential harvest of most fish stocks largely unrelated to abundance
5. Scripps Florida scientists uncover potential drug target to block cell death in Parkinsons disease
6. Tree seeds offer potential for sustainable biofuels
7. BPA linked to potential adverse effects on heart and kidneys
8. Transplanted genetically-modified adipose cells offer potential therapy for liver diseases
9. Serendipity points to new potential target and therapy for melanoma
10. Potential gene therapy approach to sickle cell disease highlighted at ASH
11. New coronavirus has many potential hosts, could pass from animals to humans repeatedly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... Juan Manuel Santos has presented Dr. Cristin Samper, ... with the prestigious Order of San Carlos. , ... foreign civilians and military officers who have made ... field of international relations. , An international authority ... was invited to the Colombian Residence in New ...
(Date:9/29/2014)... Va.September 29, 2014Research!America,s 19th annual Advocacy Awards ... who are trailblazers in advancing medical progress to ... nation. The event will take place on Wednesday, ... Auditorium in Washington, DC. , The 2015 Advocacy ... Robin Roberts; Michael Milken, founder of the Milken ...
(Date:9/29/2014)... 29, 2014 Growing Demand ... with Increasing Security Concerns Continue to Propel Biometrics ... is one of the fastest growing ... biometrics systems, majorly in various government projects such ... modality based biometrics dominates the country,s biometrics market, ...
Breaking Biology News(10 mins):Research!America to honor leaders in medical and health research advocacy 2Research!America to honor leaders in medical and health research advocacy 3Research!America to honor leaders in medical and health research advocacy 4India Biometrics Market to Surpass USD2.7 Billion by 2019, Finds TechSci Research Study 2India Biometrics Market to Surpass USD2.7 Billion by 2019, Finds TechSci Research Study 3
... Bar Harbor, Maine - Currently, 5-8% of the ... ( www.niaid.nih.gov ). Many of these are chronic ... aggregate within a single family, suggesting they are ... To help researchers investigate these common pathways, ...
... UT Southwestern Medical Center have eliminated non-small cell lung ... called BEZ235 in combination with low-dose radiation. In ... Cancer Research , UT Southwestern researchers found that if ... tumor cells with otherwise nontoxic radiation, the drug blocked ...
... are reporting results of one of the first studies ... anti-odor, anti-bacterial socks now on the market. Their findings, ... Environmental Science & Technology , may suggest ways ... these particles to the environment, where they could harm ...
Cached Biology News:UT Southwestern researchers use drug-radiation combo to eradicate lung cancer 2
(Date:9/26/2014)... Synedgen announced today the award ... Phase I contract from the National Cancer Institute ... to demonstrate proof-of-concept activity of Synedgen’s proprietary treatment ... tissue damage to the lining of the gastrointestinal ... award, Synedgen will complete efficacy studies for its ...
(Date:9/26/2014)... China Cord Blood Corporation (NYSE: CO ) ("CCBC" ... cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem ... 2014 annual general meeting of shareholders at its Hong ... Garden Road, Central, Hong Kong , at 9:00 ... Eastern Time on December 11, 2014). Shareholders of record ...
(Date:9/26/2014)... Molecular Biology deals with the ... regulation of cellular activity and its behaviour. It emphasise ... with its environment within the genome. Knowledge on molecular ... therapeutic methodologies for the diagnosis, prognosis and the treatment ... Dr. Srinubabu Gedela, MD of OMICS Publishing Group ...
(Date:9/26/2014)... “Inflamax’s Clinical Data Management group is a SCDM ... allows us to support our group in maintaining the ... Director of Data Management at Inflamax. “Being an ... Clinical Data Managers have been certified by passing the ... offering only the best services to our clients, by ...
Breaking Biology Technology:Synedgen Awarded National Cancer Institute Funding for Promising New Treatment for Medical Radiation-induced Bowel Injury 2China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 11, 2014 2Understanding Genetics and Molecular Biology to Avert Dreadful Medical Challenges during Open Access Week 2Understanding Genetics and Molecular Biology to Avert Dreadful Medical Challenges during Open Access Week 3
... N.Y., Nov. 5 BioSpecifics Technologies Corp. (Nasdaq: ... today announced its financial results for the third quarter ... happy that, in September of this year, the FDA,s ... 12-0, the approval of XIAFLEX(TM) for the treatment of ...
... November 5, 2009 Senomyx, Inc. (Nasdaq: SNMX ), ... discover novel flavor ingredients for the food, beverage, and ingredient ... results for the third quarter ended September 30, 2009. ... compared to $4.0 million for the third quarter of 2008, ...
... PLYMOUTH MEETING, Pa., Nov. 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Corporation (Nasdaq: ... the Company plans to release third quarter 2009 financial results ... The Company will hold a conference call ... quarter 2009 results. Listeners may access the call by,dialing ...
Cached Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BMP Sunstone to Report Third Quarter 2009 Financial Results 2
... DNA120OP is specifically engineered for efficient drying ... incorporates a glass cover and a post-trap ... unattended, odor-free processing of samples in ammonium ... Synthetic Oligos , ...
... Maxi MB (for aqueous, other low volatility ... systems respond to specific applications of molecular ... concentration of heat-labile samples. The RC systems ... cold traps and a wide selection of ...
... The DNA120 is a dedicated concentrator for ... precipitates of DNA/RNA. The integrated system combines ... pump. The compact design, automatic pump and ... run time; one for heater time), makes ...
... 1 Block MBS Start up kit. Includes ... and choice of 1 MultiBlock satellite ... 30 blocks. User friendly software. ... Adjustable height heated lid. Outstanding uniformity. ...
Biology Products: